Intervention Review

You have free access to this content

Dehumidifiers for chronic asthma

  1. Meenu Singh1,*,
  2. Nishant Jaiswal2

Editorial Group: Cochrane Airways Group

Published Online: 13 JUN 2013

DOI: 10.1002/14651858.CD003563.pub2


How to Cite

Singh M, Jaiswal N. Dehumidifiers for chronic asthma. Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD003563. DOI: 10.1002/14651858.CD003563.pub2.

Author Information

  1. 1

    Post Graduate Institute of Medical Education and Research, Department of Pediatrics, Chandigarh, India

  2. 2

    Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research, ICMR Advanced Centre for Evidence-Based Child Health, Chandigarh, India

*Meenu Singh, Department of Pediatrics, Post Graduate Institute of Medical Education and Research, Sector 12, Chandigarh, 160012, India. meenusingh4@gmail.com. meenusingh@rediffmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 13 JUN 2013

SEARCH

[Figure 1]
Figure 1. 'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.
[Analysis 1.1]
Analysis 1.1. Comparison 1 MHRV versus placebo, Outcome 1 Change in morning PEF at 12 months (% predicted).
[Analysis 1.2]
Analysis 1.2. Comparison 1 MHRV versus placebo, Outcome 2 Change in evening PEF at 12 months (% predicted).
[Analysis 1.3]
Analysis 1.3. Comparison 1 MHRV versus placebo, Outcome 3 Change in FEV1 at 12 months (% predicted).
[Analysis 1.4]
Analysis 1.4. Comparison 1 MHRV versus placebo, Outcome 4 Change in rescue medication (puffs/day) after 12 months.
[Analysis 1.5]
Analysis 1.5. Comparison 1 MHRV versus placebo, Outcome 5 Change in ACQ score after 12 months.
[Analysis 1.6]
Analysis 1.6. Comparison 1 MHRV versus placebo, Outcome 6 Change in SGRQ score after 12 months.
[Analysis 1.7]
Analysis 1.7. Comparison 1 MHRV versus placebo, Outcome 7 Exacerbations needing oral steroids.
[Analysis 1.8]
Analysis 1.8. Comparison 1 MHRV versus placebo, Outcome 8 Exacerbation needing GP visit.
[Analysis 1.9]
Analysis 1.9. Comparison 1 MHRV versus placebo, Outcome 9 Exacerbation needing GP out of hours.
[Analysis 1.10]
Analysis 1.10. Comparison 1 MHRV versus placebo, Outcome 10 Exacerbations needing ED visit.
[Analysis 1.11]
Analysis 1.11. Comparison 1 MHRV versus placebo, Outcome 11 Exacerbations needing hospitalisation.